Cannabics Pharmaceuticals

Cannabics Pharmaceuticals Inc. (CNBX), a company developing a platform that utilizes novel drug screening tools and artificial intelligence to create cannabinoid-based cancer treatments that are more precise for patients. By developing tools to evaluate personalized efficacy, Cannabics is helping to usher cannabinoids into the future of cancer treatment. The company's R&D department is located in Israel and is licensed by the Ministry of Health to conduct scientific and clinical research on cannabinoid formulations and cancer.